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Abstract 
Background: The Greater Mekong Subregion is aiming to achieve regional malaria elimination by 2030. Though a 
shift in malaria parasite species predominance by Plasmodium vivax has been recently documented, the transmission 
of the two minor Plasmodium species, Plasmodium malariae and Plasmodium ovale spp., is poorly characterized in the 
region. This study aims to determine the prevalence of these minor species in the China–Myanmar border area and 
their genetic diversity.
Methods: Epidemiology study was conducted during passive case detection in hospitals and clinics in Myanmar 
and four counties in China along the China–Myanmar border. Cross-sectional surveys were conducted in villages 
and camps for internally displaced persons to determine the prevalence of malaria infections. Malaria infections were 
diagnosed initially by microscopy and later in the laboratory using nested PCR for the SSU rRNA genes. Plasmodium 
malariae and P. ovale infections were confirmed by sequencing the PCR products. The P. ovale subtypes were deter-
mined by sequencing the Pocytb, Pocox1 and Pog3p genes. Parasite populations were evaluated by PCR amplification 
and sequencing of the MSP-1 genes. Antifolate sensitivity was assessed by sequencing the dhfr-ts and dhps genes 
from the P. malariae and P. ovale isolates.
Results: Analysis of 2701 blood samples collected from the China–Myanmar border by nested PCR targeting 
the parasite SSU rRNA genes identified 561 malaria cases, including 161 Plasmodium falciparum, 327 P. vivax, 66 P. 
falciparum/P. vivax mixed infections, 4 P. malariae and 3 P. ovale spp. P. vivax and P. falciparum accounted for >60 and 
~30% of all malaria cases, respectively. In comparison, the prevalence of P. malariae and P. ovale spp. was very low and 
only made up ~1% of all PCR-positive cases. Nevertheless, these two species were often misidentified as P. vivax infec-
tions or completely missed by microscopy even among symptomatic patients. Phylogenetic analysis of the SSU rRNA, 
Pocytb, Pocox1 and Pog3p genes confirmed that the three P. ovale spp. isolates belonged to the subtype P. ovale curtisi. 
Low-level genetic diversity was detected in the MSP-1, dhfr and dhps genes of these minor parasite species, poten-
tially stemming from the low prevalence of these parasites preventing their mixing. Whereas most of the dhfr and 
dhps positions equivalent to those conferring antifolate resistance in P. falciparum and P. vivax were wild type, a new 
mutation S113C corresponding to the S108 position in pfdhfr was identified in two P. ovale curtisi isolates.
Conclusions: The four human malaria parasite species all occurred sympatrically at the China–Myanmar border. 
While P. vivax has become the predominant species, the two minor parasite species also occurred at very low preva-
lence but were often misidentified or missed by conventional microscopy. These minor parasite species displayed low 
levels of polymorphisms in the msp-1, dhfr and dhps genes.
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Background
Malaria in humans is caused by four main Plasmodium 
species (Plasmodium falciparum, Plasmodium vivax, 
Plasmodium malariae and Plasmodium ovale) and the 
zoonotic parasite Plasmodium knowlesi, which is found 
in many Southeast Asian countries [1]. The most virulent 
species P. falciparum is also the most prevalent parasite in 
Africa, while P. vivax is the most widely distributed para-
site outside of Africa [2]. Compared with these two spe-
cies, P. malariae and P. ovale spp. are much less prevalent 
and significantly under-studied. Plasmodium malariae 
is more or less sympatric with P. falciparum in distribu-
tion, mainly found in sub-Saharan Africa and southwest 
Pacific [3, 4]. In comparison, P. ovale spp. were thought to 
have a much more limited distribution and mostly found 
in Africa and some islands of the west Pacific [5]. Most 
published data showed that the prevalence of these two 
species has been underestimated apparently due to low 
parasitaemia, morphological resemblance with P. vivax, 
and occurrence as mixed infections with the major para-
site species [6–10]. The advent of PCR-based molecu-
lar diagnosis method has revolutionized the detection 
of low-density Plasmodium infections [11]. Molecular 
genotyping also led to the division of P. ovale spp. into 
two distinct subspecies: P. ovale curtisi (Poc, the classic 
type) and P. ovale wallikeri (Pow, the variant type) [12]. 
The nuclear genome sequences further confirmed that 
Poc and Pow are genetically distinct but morphologically 
indistinguishable [13]. Further refinements and applica-
tions of the molecular methods have enabled enhanced 
detection of these parasites in molecular surveillance 
in endemic countries (e.g., [14–17]) as well as imported 
cases [18].
In the Greater Mekong Subregion (GMS) of Southeast 
Asia, which includes Cambodia, China, Laos, Myanmar, 
Thailand, and Vietnam, recent achievements in malaria 
control have motivated countries within this region to 
plan for regional malaria elimination by 2030. In this 
region, all five Plasmodium parasites infecting humans 
co-exist [19], and P. vivax and P. falciparum are the pre-
dominant parasite species. In contrast, other parasite 
species have been detected at much lower prevalence. 
Plasmodium malariae infections have been described 
in Cambodia [20–22], China [16, 23], Laos [19], Myan-
mar [24, 25], Thailand [11, 26–28], and Vietnam [19, 29, 
30]. The detection of field isolates with variations in both 
morphology and the SSU rRNA gene suggests that P. 
malariae may exhibit high genetic diversity [23, 24]. Sim-
ilarly, P. ovale spp. have been found in all nations of the 
GMS including Cambodia [21, 22], Laos [31, 32], Myan-
mar [16, 33, 34], Thailand [11, 26, 27], and Vietnam [30, 
35]. Although a P. ovale-like case was described in 1941 
in Yunnan [36], most, if not all, P. ovale spp. reported in 
China in recent years were imported, mainly from Africa 
[37, 38]. Both the classic and variant types of P. ovale spp. 
were identified in autochthonous as well as imported 
cases [19, 37].
In the final stage of malaria elimination, new strate-
gies tailored for rapid identification of new cases, pre-
vention of local spread, and efficient management of 
malaria introduction are critical. Especially, malaria in 
the GMS is highly heterogeneous with transmission foci 
located along international borders [39]. Hence, malaria 
re-introduction as a result of cross-border human migra-
tion needs to be dealt with, and malaria elimination may 
require regional cooperative initiatives [40]. Routine 
malaria surveillance in endemic regions largely relies on 
microscopy of Giemsa-stained blood smears and rapid 
diagnostic tests (RDT). Given that P. malariae and P. 
ovale infections often present with a low parasitaemia 
and occur as mixed infections with P. falciparum and P. 
vivax [23, 33], molecular methods of detection provide a 
more accurate estimate of malaria epidemiology. In this 
study, blood samples collected from the China–Myanmar 




This molecular epidemiology study was carried out in 
two study sites on both sides of the China–Myanmar 
border. In Myanmar, passive case detection (PCD) was 
performed in a hospital located in the Laiza Township 
and several nearby malaria clinics, Kachin State, between 
May 2011 and December 2012. In 2012, to obtain malaria 
prevalence information, cross-sectional surveys (CSS) 
were conducted in ten surrounding villages. In addi-
tion, active case detection (ACD) was also conducted 
through weekly (April–September) or biweekly (Octo-
ber–March) home visits to assess clinical malaria. From 
2010, both ACD and PCD activities were started in three 
nearby camps for internally displaced people (IDP), 
which were newly established as a result of internal mili-
tary strife. The Myanmar study site is located in one of 
Keywords: Plasmodium falciparum, Plasmodium vivax, Plasmodium malariae, Plasmodium ovale, Prevalence, Genetic 
diversity, Molecular identification
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the designated Special Zones [25], where malaria burden 
is particularly heavy and local public health infrastruc-
ture is poor. In China, PCD was performed in county and 
township hospitals of Tengchong, Yingjiang, Longchuan 
and Ruili counties, Yunnan Province in 2011–2012. Yun-
nan is the most malaria prevalent province in China and 
imported cases as cross-border migration made up a 
major part of malaria cases in Yunnan in recent years [38, 
41].
Malaria parasite samples
In Kachin, 1106 blood samples were obtained during 
PCD activities from febrile patients attending the hospi-
tal and malaria clinics, and 638 were from participants 
of two CSS (Table 1). In addition, 854 samples were col-
lected from participants in three nearby IDP camps 
in 2012. Among them, 366 were from febrile patients 
attending the malaria clinic, 411 were healthy people 
during the CSS, and 77 were febrile patients identified 
during weekly or bi-weekly ACD visits. Further, 103 
samples were collected from malaria patients attending 
hospitals in the four counties of Yunnan in 2011–2012. 
During these surveys, written informed consent and 
assent for minors were obtained and demographic data 
were collected using questionnaires. All diagnosis was 
done by microscopic examination of both thick and thin 
blood smears. All samples collected from Yunnan Prov-
ince were evaluated by RDT (Malaria Pv/Pf Test Device, 
Tycolpharm Co., Limited, UK), a Pf/Pan device based on 
pan-pLDH [34]. Finger-prick blood drops were collected 
by trained nurses on Whatman 3M filter paper, air-dried, 
and stored at −20 °C before processing. Parasite density 
was estimated using thick smears assuming 8000 leuko-
cytes/μL of blood [34]. The study protocol was reviewed 
and approved by the Institutional Review Boards of the 
Pennsylvania State University, USA, Kunming Medical 
University, China and the local Bureau of Health, Kachin 
State, Myanmar.
Screening for Plasmodium malariae and Plasmodium ovale 
spp
Genomic DNA was extracted from dried blood spots 
on filter paper using the Qiagen DNA Mini Kit accord-
ing to the manufacturer’s instruction (Qiagen, Ger-
many). Nested PCR was performed to screen malaria 
infectious from these 2701 blood samples. Primers 
rPLU5 and rPLU6 were used for the primary PCR, 
whereas primers rFAL1/2, Pv18SF/R, Pm18SF/R, 
Po18SF/R, and Pk18SF/R, specific for each of the four 
human malaria parasite species as well as P. knowlesi, 
were used for the nested PCR [42]. The PCR positive 
samples of P. malariae and P. ovale spp. were further 
confirmed by sequencing the PCR products. Some of 
the blood smears with inconsistent diagnosis results 
between the original microscopy and PCR were re-
examined to verify the presence of parasite-infected 
red blood cells.
Molecular characterization of P. malariae and P. ovale 
isolates
To further characterize the P. malariae and P. ovale iso-
lates, several genes were amplified and sequenced using 
primers listed in Additional file  1. These include the 
cytochrome b (cytb), cytochrome oxidase subunit 1 (cox1) 
and glyceraldehyde-3-phosphate (g3p) genes of P. ovale 
spp., dihydropoteroate synthase (dhps) of P. malariae 
[43], dihydrofolate reductase (dhfr) and MSP-1 genes in 
both species [44–46]. Amplified fragments of DNA were 
purified, and sequenced directly or cloned into pMD18-T 
vector (Takara) for sequencing. Sequences were assem-
bled using Lasergene (DNASTAR). The sequences deter-
mined in this study were deposited in GenBank with 
accession numbers KX672017-KX672048.
Sequence analysis
Sequences were searched in the GenBank by using the 
BLAST program. Orthologous sequences of P. malariae 
Table 1 Surveillance of malaria in Kachin State, Myanmar and four border counties of Yunnan Province, China
Plasmodium species: Pf (P. falciparum), Pv (P. vivax), Pm (P. malariae), and Po (P. ovale)
PCD passive case detection; CSS cross-sectional surveillance; ACD active case detection; RDT rapid diagnostic test
Location Surveys Method Pf Pv Pm Po Pf and Pv Total positive Total
Myanmar PCD Microscopy 128 253 1 0 34 416 (28.3%) 1472
PCR 136 257 3 2 63 461 (31.3%)
CSS Microscopy 4 13 0 0 3 20 (1.9%) 1049
PCR 8 22 0 0 0 30 (2.9%)
ACD Microscopy 0 1 0 0 0 1 (1.3%) 77
PCR 0 1 0 0 0 1 (1.3%)
Yunnan PCD RDT 18 42 0 0 1 61 (59.2%) 103
PCR 17 47 1 1 3 69 (67.0%)
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and P. ovale spp. were retrieved from the GenBank and 
PlasmoDB (http://www.plasmodb.org) for phyloge-
netic analysis. GenBank accession numbers of the genes 
included in sequence analysis are shown in Additional 
file  2. Nucleotide and deduced amino acid sequences 
were aligned by using CLUSTALW. Phylogenetic trees 
were constructed using the Neighbor-Joining method 
implemented in MEGA6 [47].
Results
Malaria case detection under the PCD and ACD efforts
For malaria surveillance along the China–Myanmar bor-
der, PCD was conducted in clinics and hospitals, while 
ACD and CSS were performed in the surrounding vil-
lages and IDP camps near Laiza township of Kachin 
State, Myanmar. On the Myanmar side, malaria diagno-
sis in hospitals and clinics was performed primarily by 
microscopy, and overall 28.3% of patients with febrile 
illness were diagnosed as having malaria infections 
and treated (Table  1). In Kachin State, the ACD efforts 
detected only one malaria case from 77 (1.3%) villagers 
with fever symptoms. Malaria prevalence in the villages 
and camps was low; CSS only detected 1.9% of the par-
ticipants as having asymptomatic Plasmodium infections 
(Table  1). More specifically, malaria prevalence (slide 
positivity) in the villages was 1.3% (8/638), whereas it was 
slightly higher (2.9%, 12/411) in the IDP camps. In this 
border region, P. vivax and P. falciparum were the pre-
dominant parasite species. In Myanmar, among the 437 
malaria cases identified by microscopy, P. vivax, P. fal-
ciparum and P. malariae infections accounted for 61.1, 
30.2 and 0.2%, respectively (Table  1). In addition, 8.5% 
of these cases were diagnosed as mixed P. falciparum/P. 
vivax infections. In the four border counties of Yunnan 
Province, China, 59.2% of febrile cases suspected for 
malaria infections were diagnosed by an RDT as malaria 
cases. Among the 61 positive cases, 68.9, 29.5 and 1.6% 
were due to P. vivax, P. falciparum and mixed infections 
of these two species.
For a more accurate identification of parasite spe-
cies, nested PCR targeting the parasite SSU rRNA genes 
was used to analyze the 2701 blood samples. For both 
PCD and CSS efforts, PCR detected more malaria cases 
(Table 1). For PCD in Myanmar, microscopy missed 9.8% 
(45/461) of malaria cases among the febrile patients. Fur-
thermore, PCR detected 13.7% (63/461) of the malaria 
cases as mixed P. falciparum/P. vivax infection as com-
pared to 7.4% (34/461) determined by microscopy. For 
the CSS efforts, PCR detected 2.9% of participants carry-
ing Plasmodium infections, an increase of 1% compared 
with that of microscopic diagnosis. In Yunnan, PCR also 
improved the RDT diagnosis sensitivity by 7.8%. In com-
parison, there were 41 discrepancies between the results 
of microscopy and PCR (Additional file 3). Six were slide-
positive but PCR negative (one P. falciparum and five P. 
vivax). Of 26 cases diagnosed as mixed-species infections 
by microscopy, 22 were P. falciparum and 4 were P. vivax 
single infections. In addition, nine slide-positive cases 
were identified as infections by a different species (Addi-
tional file 3).
For the minor Plasmodium species, whereas no P. 
knowlesi infections were identified, PCR detected a total 
of four P. malariae and three P. ovale cases (Table  1). 
Of the four P. malariae cases, only one was correctly 
identified, and the remaining three were misdiag-
nosed as P. vivax infections by microscopy. In addition, 
one P. malariae case was diagnosed by the RDT as a P. 
vivax infection. Two P. ovale cases were missed by both 
microscopy and RDT, probably due to low parasitemias, 
whereas one was misdiagnosed as P. vivax infection. Both 
parasite species had very low prevalence of 1.2% (7/561) 
in PCR-confirmed positive cases. In total, infections by 
the two minor Plasmodium species only made up 0.26% 
(7/2701) of all febrile cases at the hospitals and clinics. It 
is also noteworthy that all P. malariae and P. ovale cases 
were from PCD surveys. Most P. malariae and P. ovale 
patients presented with fever at the time of examination 
(>37.5 °C) and had 2–5 days of fever histories (Table 2). 
These cases with disparate diagnosis results between the 
original microscopy and PCR were re-examined by an 
expert microscopist, who confirmed the PCR results.
Confirmation of P. malariae and P. ovale cases
The PCR products of the SSU rRNA genes of the two 
minor species from the positive cases were cloned and 
sequenced. BLAST analysis and alignment of sequences 
showed that the four P. malariae SSU rRNA gene 
sequences had 99% identities with those from published 
P. malariae sequences, whereas the P. ovale SSU rRNA 
gene sequences from the three isolates were most closely 
related to those of P. ovale spp. with 99% identities. Con-
sistently, phylogenetic analysis showed all four P. malar-
iae SSU rRNA gene sequences were grouped together 
with other P. malariae sequences, whereas the three clin-
ical P. ovale isolates were clustered with P. ovale curtisi 
(Fig. 1).
Plasmodium ovale subtype characterization
Plasmodium ovale spp. are divided into two genetically 
distinct subspecies, Poc and Pow [12]. To further confirm 
that the P. ovale isolates identified in this study belong to 
Poc, two mitochondrial genes Pocytb (508 bp) and Pocox1 
(861 bp), and one nuclear gene Pog3p (359 bp) from the 
three clinical isolates we amplified, sequenced and com-
pared with the reference sequences (Table 3). It is obvi-
ous that the three clinical isolates were more closely 
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related to Poc than to Pow. Phylogenetic analysis of these 
three genes all confirmed that the three P. ovale isolates 
belonged to the Poc subtype.
Diversity of the MSP‑1 genes
To study the genetic diversity of these two minor Plasmo-
dium species in the China–Myanmar border area, four 
overlapping fragments of the Pmmsp-1 gene and three 
overlapping fragments of the Pomsp-1 gene were ampli-
fied by nested PCR from three (3/4) P. malariae isolates 
(M0N00290, M0N00556 and M0N00648) and two (2/3) P. 
ovale isolates (C0100511 and M0500214), and sequenced. 
The assembled PmMSP-1 sequences were 5160  bp 
(M0N00648) and 5150  bp (M0N00290 and M0N00556) 
in length, whereas the PoMSP-1 sequences were both 
5157 bp. Alignment of the PmMSP-1 sequences with the 
full-length sequence of a Cameroonian isolate MM1A 
(GenBank #FJ824669) [45] revealed nucleotide and 
amino acid identities of ~98 and ~97%, respectively. 
Alignment of the PmMSP-1 sequences from this study 
with the sequences of 11 Brazilian isolates by fragments 
showed that fragment 2 sequences corresponding to 
amino acids 637–858 in the MM1A sequence were the 
most polymorphic with 87.3–88.9 and 82.3–83.6% identi-
ties in the nucleotide and amino acid sequences, respec-
tively (Additional file  4). Fragment 4, corresponding to 
amino acids 1366–1512 in the MM1A sequence, was 
absolutely conserved in the P. malariae isolates analyzed 
in this study.
The two Pomsp-1 sequences encoding 1718 amino 
acids were 100% identical. They were >98% identical in 
nucleotide sequence with the Pocmsp-1 sequence from 
the Cameroonian isolates OM1A and OM1B (GenBank 
#FJ824670 and FJ824671), and ~91% identical with the 
Powmsp-1 from the Thai isolates (Additional file 5). Com-
parison of the amino acid sequences showed a similar 
trend. Compared with the PoMSP-1 gene from the Thai 
isolate Po-7 (GenBank No. KC137346) [48], there are 
two synonymous mutations (C421T and T1929C) and 
one nonsynonymous mutation (C541T) in the isolate 
C0100511. A 12-nucleotide repeat sequence (GCCGC-
TACACAA) encoding amino acids AATQ between the 
position 2814–2911 in the variable domain 5 was found 
to have repeated three times in the Thai isolate and four 
times in both C0100511 and M0500214 (Additional 
file 6). The highest amino acid identity in the other vari-
able domains and interspecies conserved sequences of 
PoMSP-1 was observed among the M0500214, C0100511 
and five Poc isolates (Po-4, Po-7, Po-8, Po-9, Po-10) from 
Thailand.
The dhfr‑ts genes from P. malariae and P. ovale isolates
The dhfr-ts gene from the four P. malariae isolates 
and three Poc isolates were amplified and sequenced. 
The four P. malariae dhfr-ts genes ranged in size from 
1678 to 1779  bp, encoding proteins of 559–592 amino 
acids and corresponding to amino acids 13–604 of the 
PmDHFR-TS from the Thai isolate Pm3 (GenBank 
#EF188271) [44] (Additional file  7). Three of the four 
isolates from the China–Myanmar border area had a 
PmDHFR sequence identical to that of the Thai Pm3 iso-
late, whereas M0N00648 contained two new mutations, 
L137P and K161R (Table  4; Additional file  7). All four 
PmDHFR-TS sequences from the China–Myanmar bor-
der isolates were wild type at amino acids S49, N50, S58, 
S114 and I170, which correspond to amino acids C50, 
N51, C59, S108 and I164 in PfDHFR, respectively. Muta-
tions at these sites are known to confer pyrimethamine 
resistance [49, 50]. Two of the four PmDHFR sequences 
also contained amino acids A15 corresponding to A16 
in PfDHFR. Of note, the S49 and S58 in PmDHFR-TS 
were different from the C50 and C59 in the PfDHFR 
Table 2 Characteristics of the P. malariae and P. ovale cases
ND not done
a Cases detected in Myanmar
b Cases detected in Yunnan
c Parasites/μl of blood




M0500214a 27 M – – P. ovale 40.0 – –
M0102751a 7 M – – P. ovale 38.6 – –
C0100511b 33 M Pv Pv P. ovale 38.9 800 400
M0N00648a 30 M Pm ND P. malariae 38.0 880 40
M0N00556a 11 F Pv ND P. malariae 39.5 2120 4800
M0N00290a 29 M Pv ND P. malariae 36.0 80 1600
C0400117b 22 M Pv Pv P. malariae 40.5 400 160
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sequence. Mutations N50K, K55E, S58R, S59A, S114N/G 
and I170M found in other PmDHFR sequences [44, 51] 
were not observed in the PmDHFR sequences from the 
China–Myanmar border isolates (Table  4; Additional 
file 7).
The three sequences of the Podhfr-ts gene ranged 
from 1673 to 1757  bp and encode proteins of 557–585 
amino acids, corresponding to amino acids 24–608 of the 
PocDHFR-TS from the Indian isolate Po2003 (GenBank 
#KP050405) [52] (Additional file  7). Sequence polymor-
phisms were found at positions A62, C113, H231 and 
E370 in PocDHFR-TS from the isolate M0102751, while 
isolate M0500214 only contained C113 (Table  4; Addi-
tional file 7). Similarly, Y49 and S58 in PocDHFR-TS were 
different from C50 and C59 in the PfDHFR-TS sequence. 
Also, C113 in PocDHFR-TS from the isolate M0102751 
and M0500214 was different from S108 in the PfDHFR-
TS (Table 4).
Fig. 1 Phylogenetic relationship based on the SSU rRNA sequences from Plasmodium species (GenBank accession numbers are in brackets). Black 
circles and triangles represent the P. ovale and the P. malariae isolates respectively from China–Myanmar border area in this study. CN China; CR Costa 
Rica; ET Ethiopia; ID Indonesia; MM Myanmar; MY Malaysia; PG Papua New Guinea; VE Venezuela
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Sequencing analysis of the dhps genes from P. malariae
The Pmdhps gene was successfully amplified from the 
four P. malariae isolates. The partial Pmdhps gene was 
962  bp in length and encoded 320 amino acids, corre-
sponding to amino acids 347–659 in PfDHPS. The four 
PmDHPS sequences from the China–Myanmar border 
area isolates were identical to the PmDHPS haplotype 
1 reported earlier [43] (Additional file 8). The six amino 
acids in PmDHPS equivalent to the residues associated 
with sulfadoxine resistance in PfDHPS (S436, K540, 
A581, I588 and A613) were all wild type except the 
mutant A437G.
Discussion
Accurate knowledge of the malaria epidemiology is 
essential for guiding control and elimination efforts. This 
study employed both ACD and PCD along the interna-
tional borders between China and Myanmar, and used 
a molecular detection method in order to more accu-
rately determine the infection prevalence among febrile 
patients and asymptomatic residents, and parasite spe-
cies compositions. In this border region, malaria is sea-
sonal with all four human malaria parasites. While P. 
vivax has become the predominant parasite species 
followed by P. falciparum [16, 53], the two minor para-
site species P. malariae and P. ovale spp. were detected 
at very low frequencies in patients presenting in hospi-
tals and clinics with acute febrile illness. It is important 
to note that three of the four P. malariae cases and one 
P. ovale case were misidentified as P. vivax infections 
by microscopy and treated with the chloroquine/pri-
maquine combination, whereas two P. ovale cases were 
missed by microscopy and thus were not treated with 
anti-malarial drugs. Furthermore, PCR also identified 
more mixed-species infections, which may not have been 
treated properly depending on the results of the initial 
diagnosis. Thus, more sensitive diagnosis may well be 
needed for “border malaria” in order to completely elimi-
nate malaria transmission.
Published data to date showed that the dhfr genes in 
Poc and Pow were highly conserved in codons poten-
tially mediating pyrimethamine resistance, although 
isolates carrying double A15S and S58R mutations were 
observed in imported cases in Singapore [12, 52]. The 
four P. malariae cases and three P. ovale cases detected 
in this study did not show mutations at equivalent resi-
dues responsible for antifolate resistance in other Plas-
modium, while two new mutations at positions L137P 
and K161R were observed in one P. malariae isolate and 
four new mutations were observed at positions T62A, 
S113C, Y231H and K370E in Podhfr. It is noteworthy that 
the S113C mutation in the Pocdhfr corresponds to amino 
acid S108 in Pfdhfr, the primary position associated with 
pyrimethamine resistance [50, 54], but it is not known 
whether S113C mutation also confers pyrimethamine 
resistance in Poc. Similarly, Pmdhps gene also showed 
limited genetic diversity and all four isolates from the 
China–Myanmar border were identical to the PmDHPS 
haplotype 1, which was most prevalent in Asian coun-
tries [43].
MSP-1 as a predominant merozoite surface antigen is 
present in all examined Plasmodium species. P. falcipa-
rum and P. vivax MSP-1 genes display extensive genetic 
diversity, which is often used as a molecular marker for 
population studies. To date, limited studies on PmMSP-1 
among Brazilian isolates and PocMSP-1 on Thai isolates 
detected low-level sequence diversity with most of varia-
tions located at interspecies variable domains of this gene 
[46, 48]. Phylogenetic analysis of PmMSP-1 using the 
maximum likelihood method placed the China–Myan-
mar border isolates separated from the Brazilian isolates, 
indicating divergent parasite populations. Furthermore, 
the PocMSP-1 sequences from the China–Myanmar bor-
der isolates were highly conserved and also displayed a 
Table 3 Nucleotide substitutions in Pocyt b, Pocox 1 and Pog3p compared with the sequences in Poc and Pow
Isolates Genes
Pocyt b (508 bp) Pocox 1 (861 bp) Pog3p (359 bp)
53 94 95 147 305 317 335 437 446 464 80 89 93 104 206 263 288 461 475 597 713 33 51 57 78 87 132 180 240 252 276 285 304 321
C0100511 T   T  C  A   G   C   T    T   C   C T   T  C  C   T G   C   C   A   A   T T  C   A  A  T  A   C   A   T    T   T   A   G
M0102751 T   A C  A   G   C   T    T   C   C T   T  C  C   T    G   C   C   T A   T T  C   A  A  T  A   C   A   T    T   T   T G
M0500214 T   T  C  G G   C   T    C C   C T T  C  C   T    G   C   C   A   A   T T  C   A  A  T  A   C   A   T    T   T   A   G
Poc T   T  C  A   G   C   T    T   C   C T   T  C  C   T    G   C   C   A   A   T T  C   A  A  T  A   C   A   T    T   T   A   G
Pow A   T  T  A   T   T   A    T   T   T C   C  T  T   G    A   T   T   A   G   A A  T   T  G  G  T   T   C   C    C   A   A   T
Numbering was according to the submitted sequence to GenBank. The GenBank access numbers: Pocyt b: KX672027 (M0500214), KX672028 (M0102751), KX672029 
(C0100511); Pocox 1: KX672024 (M0500214), KX672025 (M0102751), KX672026 (C0100511); Pog3p: KX672030 (M0500214), KX672031 (M0102751), KX672032 
(C0100511). The GenBank access numbers of the reference sequences for the three Poc genes are HQ712052, HQ712052 and KP050383, respectively; and for the three 
Pow genes are KP050428, KP050417, and KP050384, respectively. Nucleotides that are different from the type Poc sequence are shadowed
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high level of similarity with the PocMSP-1 from the Thai 
isolates. Apparently, future studies with larger popula-
tions of the two minor parasite species are warranted.
Conclusions
Malaria epidemiology at the China–Myanmar bor-
der has shifted to P. vivax predominance, while the two 
minor parasite species P. malariae and P. ovale spp. also 
occurred at very low prevalence. However, these minor 
species were most often misidentified or missed, high-
lighting a potential problem in malaria treatment. Molec-
ular studies identified the P. ovale spp. as the subspecies 
Poc. Characterization of two antifolate genes dhfr and 
dhps revealed significant conservation at most positions 
possibly conferring antifolate resistance in P. falciparum 
and P. vivax, suggesting reduced impacts of antifolate 
selection on these two minor parasite species. Despite 
this, the S113C mutation, corresponding to S108 posi-
tion in Pfdhfr, was first reported here in two Poc isolates 
from the China–Myanmar border area. Further analysis 
of the MSP-1 gene also revealed much lower levels of 
genetic diversity than their orthologs in P. falciparum and 
P. vivax populations, possibly due to the persistent low 
prevalence of these minor species in the GMS.
Abbreviations
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